Javascript must be enabled to continue!
Abstract 117: DOT1L is a human chromosome stability gene
View through CrossRef
Abstract
The loss of genome stability is an early event that drives the development and progression of virtually all tumor types. Recent studies have revealed that certain histone post-translational modifications exhibit dynamic and global increases in abundance that coincide with mitosis and exhibit essential roles in maintaining genomic stability. Histone H2B ubiquitination at lysine 120 (H2Bub1) is regulated by RNF20, an E3 ubiquitin ligase that is mutated/altered in numerous tumor types. Through an evolutionarily conserved trans-histone pathway, H2Bub1 is an essential pre-requisite for subsequent downstream di-methylation events at lysines 4 (H3K4me2) and 79 (H3K79me2) of histone H3. Although the role that RNF20 plays in tumorigenesis has garnered much attention, the downstream components of the trans-histone pathway, H3K4me2 and H3K79me2, and their potential contributions to genome stability remain largely overlooked. In this study, we employ single-cell imaging, and biochemical approaches to investigate the spatial and temporal patterning of RNF20, H2Bub1, H3K4me2 and H3K79me2 throughout the cell cycle. Using two independent human cell lines, we show that H2Bub1, H3K4me2 and H3K79me2 exhibit distinct temporal progression patterns throughout the cell cycle. Most notably, we demonstrate that H3K79me2 is a highly dynamic histone PTM that reaches maximal abundance during mitosis in an H2Bub1-independent manner. Using RNAi and chemical genetic approaches, we identify DOT1L as the histone methyltransferase responsible for mitotic-associated increases in H3K79me2. We also demonstrate that the loss of mitotic H3K79me2 levels correlates with increases in chromosome numbers and increases in mitotic defects. Collectively, these data suggest that H3K79me2 dynamics during mitosis are normally required to maintain genome stability and further implicate the loss of H3K79me2 during mitosis as a pathogenic event that contributes to the development and progression of tumors.
Citation Format: Brent Guppy, Kirk McManus. DOT1L is a human chromosome stability gene. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 117. doi:10.1158/1538-7445.AM2015-117
Title: Abstract 117: DOT1L is a human chromosome stability gene
Description:
Abstract
The loss of genome stability is an early event that drives the development and progression of virtually all tumor types.
Recent studies have revealed that certain histone post-translational modifications exhibit dynamic and global increases in abundance that coincide with mitosis and exhibit essential roles in maintaining genomic stability.
Histone H2B ubiquitination at lysine 120 (H2Bub1) is regulated by RNF20, an E3 ubiquitin ligase that is mutated/altered in numerous tumor types.
Through an evolutionarily conserved trans-histone pathway, H2Bub1 is an essential pre-requisite for subsequent downstream di-methylation events at lysines 4 (H3K4me2) and 79 (H3K79me2) of histone H3.
Although the role that RNF20 plays in tumorigenesis has garnered much attention, the downstream components of the trans-histone pathway, H3K4me2 and H3K79me2, and their potential contributions to genome stability remain largely overlooked.
In this study, we employ single-cell imaging, and biochemical approaches to investigate the spatial and temporal patterning of RNF20, H2Bub1, H3K4me2 and H3K79me2 throughout the cell cycle.
Using two independent human cell lines, we show that H2Bub1, H3K4me2 and H3K79me2 exhibit distinct temporal progression patterns throughout the cell cycle.
Most notably, we demonstrate that H3K79me2 is a highly dynamic histone PTM that reaches maximal abundance during mitosis in an H2Bub1-independent manner.
Using RNAi and chemical genetic approaches, we identify DOT1L as the histone methyltransferase responsible for mitotic-associated increases in H3K79me2.
We also demonstrate that the loss of mitotic H3K79me2 levels correlates with increases in chromosome numbers and increases in mitotic defects.
Collectively, these data suggest that H3K79me2 dynamics during mitosis are normally required to maintain genome stability and further implicate the loss of H3K79me2 during mitosis as a pathogenic event that contributes to the development and progression of tumors.
Citation Format: Brent Guppy, Kirk McManus.
DOT1L is a human chromosome stability gene.
[abstract].
In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA.
Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 117.
doi:10.
1158/1538-7445.
AM2015-117.
Related Results
Connecting the DOTs on Cell Identity
Connecting the DOTs on Cell Identity
DOT1-Like (DOT1L) is the sole methyltransferase of histone H3K79, a modification enriched mainly on the bodies of actively transcribing genes. DOT1L has been extensively studied in...
2044-P: Histone Methyltransferase DOT1L Regulates Brown Adipocyte Differentiation and Thermogenesis
2044-P: Histone Methyltransferase DOT1L Regulates Brown Adipocyte Differentiation and Thermogenesis
Brown fat has been extensively studied due to its potential in therapies against obesity. Various epigenetic regulators have been shown to modulate brown fat development and functi...
The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis
The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis
AbstractIdiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease with increasing occurrence, high death rates, and unfavorable treatment regimens. The pathoge...
Abstract 1654: Discovery of the first-in-class DOT1L PROTAC degrader
Abstract 1654: Discovery of the first-in-class DOT1L PROTAC degrader
The histone methyltransferase, DOT1L is often dysregulated in MLL-rearranged (MLL-r) leukemia, which leads to hyperactivation of MLL target genes and poor prognosis. This dysregula...
Dual function of DOT1L suppresses tumor intrinsic immunogenicity in hepatocellular carcinoma
Dual function of DOT1L suppresses tumor intrinsic immunogenicity in hepatocellular carcinoma
AbstractImmune checkpoint inhibitor (ICB) therapy for many cancers remains limited in patients’ overall response rate. Discovery and development of more effective combinatorial app...
DOT1L Regulates Thermogenic Adipocyte Differentiation and Function via Modulating H3K79 Methylation
DOT1L Regulates Thermogenic Adipocyte Differentiation and Function via Modulating H3K79 Methylation
Brown
and beige adipocytes are characterized as thermogenic adipocytes and have great
potential for treating obesity and associated metabolic diseases. Here, we identify
a conserve...
DOT1L Regulates Thermogenic Adipocyte Differentiation and Function via Modulating H3K79 Methylation
DOT1L Regulates Thermogenic Adipocyte Differentiation and Function via Modulating H3K79 Methylation
Brown
and beige adipocytes are characterized as thermogenic adipocytes and have great
potential for treating obesity and associated metabolic diseases. Here, we identify
a conserve...
MDR1 Mediated Drug Resistance to a Histone Methyltansferase Inhibitor (KMT)
MDR1 Mediated Drug Resistance to a Histone Methyltansferase Inhibitor (KMT)
Abstract
Aberrant histone methylation is emerging as a major contributor to oncogenesis, and inhibitors of histone lysine methyltransferases (KMTs) are starting to e...

